Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Judy Dan Research and Treatment Centre is a premier Canadian facility dedicated to the treatment of chronic, non-healing wounds and the advancement of hyperbaric medicine. Operated by the non-profit Ontario Wound Care Inc., the center specializes in Hyperbaric Oxygen Therapy (HBOT) to prevent amputations in patients with diabetic foot ulcers and other complex conditions. It utilizes state-of-the-art technology, including monoplace hyperbaric chambers and advanced diagnostic tools like MolecuLight imaging and laser Doppler. Beyond clinical care, the center conducts significant research trials in collaboration with academic institutions to evaluate the efficacy of HBOT and new wound assessment modalities. It serves as a critical resource for patients suffering from refractory osteomyelitis, radiation-induced tissue damage, and sudden hearing loss.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Judy Dan Research and Treatment Centre.